NCT02266511View on ClinicalTrials.gov

Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

September 30, 1999

Conditions
Healthy
Interventions
DRUG

Flomax®, Norman II facility

DRUG

Flomax®, Nishine facility

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY